Latest Breaking News On - Bellerophon therapeutics inc - Page 20 : vimarsana.com

Bellerophon Therapeutics (NASDAQ:BLPH) Coverage Initiated by Analysts at Laidlaw

Laidlaw initiated coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Get Rating) in a research note published on Tuesday, The Fly reports. The firm issued a buy rating on the biotechnology company’s stock. BLPH has been the topic of a number of other reports. HC Wainwright reiterated a buy rating and issued a $30.00 price […]

Exchange commissionBellerophon therapeutics incBellerophon therapeuticsGet ratingBellerophon therapeutics dailyNasdaq blphInitiated coverage

Bellerophon Therapeutics Announces Last Patient Has Completed Blinded Treatment in Phase 3 REBUILD Study for INOpulse® in Fibrotic Interstitial Lung Disease

Bellerophon Therapeutics Announces Last Patient Has Completed Blinded Treatment in Phase 3 REBUILD Study for INOpulse® in Fibrotic Interstitial Lung Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Peter fernandesBrian ritchieBellerophon therapeutics incExchange commissionChief executiveVigorous physical activityPrivate securities litigation reform actAnnual reportSci advisorsBellerophon therapeutics

Analysts Downgrades for May 6th (BLPH, DBD, ESGR, HAS, IPI, JAKK, LLY, MHH, ROG, TAL)

Analysts’ downgrades for Saturday, May 6th: Bellerophon Therapeutics (NASDAQ:BLPH) was downgraded by analysts at StockNews.com from a hold rating to a sell rating. Diebold Nixdorf (NYSE:DBD) was downgraded by analysts at StockNews.com from a hold rating to a sell rating. Enstar Group (NASDAQ:ESGR) was downgraded by analysts at StockNews.com from a buy rating to a […]

Eli lillyEnstar groupEducation groupBellerophon therapeutics incNews ratings for bellerophon therapeutics inc dailyFuel systemsBellerophon therapeutics inc dailyDiebold nixdorf incorporatedEnstar group limitedHasbro incIntrepid potash incJakks pacific incEli lilly and companyMastech digital incKrogers coTal education group

Bellerophon Therapeutics (NASDAQ:BLPH) Raised to Hold at StockNews com

StockNews.com upgraded shares of Bellerophon Therapeutics (NASDAQ:BLPH – Get Rating) from a sell rating to a hold rating in a research report report published on Friday morning. Separately, HC Wainwright reissued a buy rating and set a $30.00 target price on shares of Bellerophon Therapeutics in a research note on Tuesday, April 4th. Bellerophon Therapeutics […]

Renaissance technologiesBellerophon therapeutics incExchange commissionBellerophon therapeuticsGet ratingBellerophon therapeutics dailyNasdaq blphStocknews com

Short Interest in Bellerophon Therapeutics, Inc (NASDAQ:BLPH) Drops By 22 3%

Bellerophon Therapeutics, Inc. (NASDAQ:BLPH – Get Rating) saw a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 434,800 shares, a drop of 22.3% from the March 31st total of 559,800 shares. Based on an average daily trading volume, of 1,190,000 shares, the short-interest ratio […]

Securities exchange commissionBellerophon therapeutics incBellerophon therapeuticsGet ratingBellerophon therapeutics dailyNasdaq blph